Denali Interim Phase I/II Data for Hunter Syndrome (MPSII) Clinical Program

Welcome to the Bioasis Technologies Hub On AGORACOM

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Denali Interim Phase I/II Data for Hunter Syndrome (MPSII) Clinical Program

posted on Jul 26, 2021 08:03AM

Denali Therapeutics Announces Positive Interim Data from Phase 1/2 Study with ETV:IDS (DNL310) in Patients with the Lysosomal Storage Disease Hunter Syndrome (MPS II)

https://www.denalitherapeutics.com/investors/press-release?id=8321&type=api

Good write up in Endpoints News on this too:

Denali slips as a snapshot of early data raises some troubling questions on its pioneering blood-brain barrier neuro work

https://endpts.com/denali-slips-as-a-snapshot-of-early-data-raises-some-troubling-questions-on-its-pioneering-blood-brain-barrier-neuro-work/

2 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply